2020 Guideline Updates and Implications to Patient Care
Originally presented on June 24, 2020 by Ted Okerson, MD, FACP, FACE, FTOS, Paul Tomasic, MD, Davida F. Kruger, MSN, APN-BC, BC-ADM, and Curtis Triplitt, PharmD, CDCES
In this panel discussion webinar, we'll review and discuss changes to the ADA/EASD treatment guidelines and the importance of treating cardiovascular disease (CVD) and diabetic kidney disease (DKD), as well as the impact of treatments on glycemia and weight. The presenters will facilitate a discussion on this impact to providers and their patients.
Upon completion of this activity, participants will be able to:
- Understand changes to the ADA/EASD treatment guidelines and importance of treating CVD and DKD
- Understand impact of treatments on glycemia and weight
- Discussion on impact to providers and patients